Effects of age and cigarette smoking on propranolol disposition.
about
Steady state pharmacokinetics of propranolol in Saudi Arabian patients and comparison with data for different populations.Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data.Drug prescribing for the elderly.A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.Comparison of pharmacokinetic profiles of single and multiple doses of a slow release Oros oxprenolol delivery system in young normotensive and elderly hypertensive subjects.Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosisThe influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentrationEffects of age and smoking on the pharmacokinetics of pindolol and propranolol.Influence of cimetidine on pharmacokinetics of propranolol.Drug metabolism and ageing.Gut wall metabolism of verapamil in older people: effects of rifampicin-mediated enzyme inductionHuman variability in susceptibility to toxic chemicals--a preliminary analysis of pharmacokinetic data from normal volunteers.Pharmacologic considerations in the positioning of beta-blockers in antihypertensive therapy.Alterations in drug disposition in older adults.Aging and determinants of hepatic drug clearance.Acebutolol: a review of its pharmacology, pharmacokinetics, clinical uses, and adverse effects.Drug metabolism in the elderly.Aging, alcohol, and the liver.Pharmacogeriatrics.The application of clearance concepts to propranolol disposition in man.On chiral drug action.Drug metabolism in the elderly: confounding of age, smoking, and ethanol effects.Pharmacology and aging.Stereoselective binding of propranolol in the elderly.Enzyme induction and beta-adrenergic receptor blocking drugs.Lack of effect of ageing on the stereochemical disposition of propranololSocial drinking and drugs.Pharmacokinetics of multiple-dose oral cilostazol in middle-age and elderly men and women.A comparative pharmacokinetic study of conventional propranolol and long acting preparation of propranolol in patients with cirrhosis and normal controls.Propranolol disposition in renal failure.Effect of age on plasma propranolol levels.Steady state relative bioavailability and pharmacokinetics of oral propranolol in black and white North Americans.The effects of age and dietary protein restriction on the pharmacokinetics of theophylline in the rat.The relevance of CYP2D6 genetic polymorphism on chronic metoprolol therapy in cardiovascular patients.The pharmacokinetics of methohexital in young and elderly subjects.The relationships between clinical response, psychophysiological variables and plasma levels of amitriptyline and diazepam in neurotic outpatients.The effect of age upon liver volume and apparent liver blood flow in healthy man.
P2860
Q30576264-0503B9F6-D88C-4B88-9D3C-39CCA9383A03Q30806355-B0C99059-C62E-4020-B6F1-7F533833CF12Q34110511-80F47597-2032-4C3B-9314-57B6A280EE69Q34447166-D3DE70F7-67B0-46B7-8EFD-8B1F3C122BEEQ34447414-75E4642C-DF05-4973-9A85-D8ACE37E8D14Q34448937-35440386-4A53-4F04-9434-53FF0066ADFCQ34448943-6A42D21A-F014-427E-8E9E-AD9CABDC7EA8Q34450364-3A1A5967-E05E-407A-91E1-FDB0C9BC3B60Q34780424-9AF055BD-BF44-4E5D-8EF8-C37C798CFE0EQ35747971-3570DC76-02B7-4723-B571-C9727CC203B4Q35802166-5F2CE768-F6D7-44AF-BBAC-DD4A7CE92F34Q36457487-386B106E-A3E6-4E53-BEFA-046448600103Q37215575-FDF2DD0B-21BD-4F37-81CE-B90382D5BC5DQ38323527-B7A5C447-F343-4DBA-90C5-6D980DFA6E29Q38599007-BAAC93F1-1D06-4A58-8C31-D34E4478D018Q39502346-007867C0-5B27-4CA6-AFFE-2C9791D9A3C7Q39522004-1187560B-C02F-4A12-B80E-A3A736F14328Q39627252-801D8902-C1F7-44DE-8B3B-C1D22EB9A7A9Q39837842-88AFCB4F-2665-43A1-B781-852311CA5C34Q39850162-6894803B-644D-42E2-9B8D-35ACD2EB6696Q40076893-E72FFCB7-C76A-4434-B04D-212EDC854900Q40147811-F9D16EE5-B7C7-4BD4-8139-020E5E1D7AE4Q40326082-883180C7-BC4F-41A7-B297-1F21AB6EDC58Q41820132-1E01A74E-8F70-463D-B62B-503A3AB0F9C9Q41987008-DFA0FF3E-B463-4E11-A870-037BFF119CB5Q42084371-27BA772C-1E2E-49E9-A313-2EC17C82F12BQ42359068-91BBD6BC-CD29-4781-B949-8522112145B9Q42676131-26A226D5-91F2-446F-AE37-D4C23492F5D8Q43229032-C699D3EC-365D-4B33-AD80-8C2F7017F3A1Q43241986-DFFEED45-32B1-4C84-920A-CE9A61867471Q43243898-631F90AD-B9BF-448E-8A93-366EFC9EF675Q46397182-6D0126BC-1969-44DE-AE13-F9A9C02EC6E5Q46889716-BCA009F6-2F30-4267-AFEB-5D7B4CFE0A4BQ46942540-8E42E737-2DE5-4289-92CB-4186E3412286Q51824784-3635CC2E-0AB2-4D6D-8702-991B3DFED06AQ51870849-FCA71C59-490E-4397-982E-C6916684E352Q53846028-3664C907-49AF-4B77-ABC0-D74B330F247E
P2860
Effects of age and cigarette smoking on propranolol disposition.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Effects of age and cigarette smoking on propranolol disposition.
@en
type
label
Effects of age and cigarette smoking on propranolol disposition.
@en
prefLabel
Effects of age and cigarette smoking on propranolol disposition.
@en
P2093
P356
P1476
Effects of age and cigarette smoking on propranolol disposition.
@en
P2093
P356
10.1002/CPT19792618
P407
P577
1979-07-01T00:00:00Z